logo
The past three years for Thungela Resources (JSE:TGA) investors has not been profitable

The past three years for Thungela Resources (JSE:TGA) investors has not been profitable

Yahoo7 days ago

For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that's been the case for longer term Thungela Resources Limited (JSE:TGA) shareholders, since the share price is down 64% in the last three years, falling well short of the market return of around 33%. And over the last year the share price fell 32%, so we doubt many shareholders are delighted. Furthermore, it's down 19% in about a quarter. That's not much fun for holders.
With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.
During the three years that the share price fell, Thungela Resources' earnings per share (EPS) dropped by 23% each year. This fall in EPS isn't far from the rate of share price decline, which was 29% per year. So it seems like sentiment towards the stock hasn't changed all that much over time. Rather, the share price has approximately tracked EPS growth.
The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).
This free interactive report on Thungela Resources' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.
When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Thungela Resources the TSR over the last 3 years was -30%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence!
The last twelve months weren't great for Thungela Resources shares, which cost holders 23%, including dividends, while the market was up about 30%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Shareholders have lost 9% per year over the last three years, so the share price drop has become steeper, over the last year; a potential symptom of as yet unsolved challenges. We would be wary of buying into a company with unsolved problems, although some investors will buy into struggling stocks if they believe the price is sufficiently attractive. It's always interesting to track share price performance over the longer term. But to understand Thungela Resources better, we need to consider many other factors. For example, we've discovered 3 warning signs for Thungela Resources (1 is significant!) that you should be aware of before investing here.
If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on South African exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tharisa PLC (TIHRF) (H1 2025) Earnings Call Highlights: Navigating Challenges with Strategic ...
Tharisa PLC (TIHRF) (H1 2025) Earnings Call Highlights: Navigating Challenges with Strategic ...

Yahoo

time28 minutes ago

  • Yahoo

Tharisa PLC (TIHRF) (H1 2025) Earnings Call Highlights: Navigating Challenges with Strategic ...

Revenue: $280.8 million, down 24% year-on-year. EBITDA: $43.8 million, down 45% year-on-year. Net Profit After Tax: $8.2 million for the half year. Cash from Operations: $36 million, down from $86 million in the prior period. Capital Expenditure: $52.5 million, with $12.8 million allocated to Karo Platinum. Cash and Cash Equivalents: $193.6 million at the end of the half year. Headline Earnings Per Share: USD0.029. Interim Dividend: USD0.015 per share, representing 54.3% of NPAT. Share Repurchase Program: Announced a second program of USD5 million. PGM Production: 62,400 ounces. Chrome Concentrate Production: 755,400 tonnes. PGM Basket Price: $1,403 per ounce, up 4.4% from the prior period. Metallurgical Chrome Concentrate Price: $253 per tonne, down 12.2%. Net Cash: $87.6 million as of March 31, 2025. Total Debt: $106.1 million, with 73% as short-term debt. Warning! GuruFocus has detected 5 Warning Sign with TIHRF. Release Date: May 22, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Tharisa PLC (TIHRF) reported industry-leading safety statistics with a lost time injury frequency rate of 0.02 at the Tharisa mine and 0.08 at Karo Platinum. The company maintained a strong cash position, ending the half-year with $193.6 million in cash and cash equivalents. Tharisa PLC (TIHRF) announced a second share repurchase program of USD5 million, following a successful first program. The company is advancing its Redox One long-duration energy storage battery to megawatt scale, indicating progress in energy storage solutions. Tharisa PLC (TIHRF) declared an interim dividend of USD0.015, maintaining a high payout ratio of 54.3% of net profit after tax, reflecting confidence in its business outlook. Revenue for the half-year decreased by 24% to $280.8 million, impacted by lower output and reduced PGM and chrome prices. EBITDA fell by 45% year-on-year to $43.8 million, reflecting operational challenges and lower commodity prices. The company faced severe weather disruptions, including thunderstorms and lightning, which affected operations in the first half. Tharisa PLC (TIHRF) experienced a decrease in net cash flow from operations, down to $36 million from $86 million in the prior period. The metallurgical chrome concentrate price dropped by 12.2%, contributing to the overall decline in revenue. Q: What is the outlook for chrome production in the next half of the year? A: Phoevos Pouroulis, CEO, stated that Tharisa has not revised its guidance and remains cautiously optimistic about meeting the lower end of its annual guidance for PGMs and chrome production. The company expects an improved second half due to a drier season and successful waste stripping to access reef horizons. Q: How is Tharisa addressing potential industrial action affecting logistics, particularly with Transnet? A: Phoevos Pouroulis, CEO, explained that Tharisa utilizes three portsRichards Bay, Durban, and Maputoproviding flexibility to redirect cargoes if needed. This multi-port strategy has proven effective in mitigating disruptions. Q: What are the implications of chrome being classified as a critical mineral in South Africa? A: Phoevos Pouroulis, CEO, welcomed the classification, noting that it aligns with Tharisa's strategy of beneficiation and product diversification. The company expects potential government support to enhance local value and accelerate projects like redox flow electrolyte production. Q: When will Tharisa's surface mine volumes start declining as underground mining ramps up? A: Phoevos Pouroulis, CEO, indicated that steady-state production from the underground mine is expected by 2029, allowing for continued open-pit mining until 2034. The transition provides flexibility and the potential to increase production capacity. Q: How is Tharisa mitigating weather-related disruptions, particularly from rainfall and lightning? A: Phoevos Pouroulis, CEO, highlighted the implementation of a comprehensive water management strategy, including dewatering boreholes and upgraded pumping capacity. For lightning, the company is considering reducing the storm scope radius to minimize operational disruptions. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio

Dow, S&P 500, Nasdaq All Positive on the Year Once Again
Dow, S&P 500, Nasdaq All Positive on the Year Once Again

Wall Street Journal

time34 minutes ago

  • Wall Street Journal

Dow, S&P 500, Nasdaq All Positive on the Year Once Again

All three major U.S. stock indexes closed in positive year-to-date territory simultaneously for the first time since Feb. 21. The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average all rose by 1%, or more, during Friday's trading. Stocks have been volatile through weeks of tariff news, but have recovered losses from recent months. This year, the S&P 500 is up 2%, the Nasdaq is up 1.1% and the Dow is up 0.5%, according to Dow Jones Market Data.

Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory

Yahoo

time37 minutes ago

  • Yahoo

Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory

We came across a bullish thesis on Alpha Cognition Inc. Common Stock (ACOG) by anygal on r/investing on Reddit. In this article, we will summarize the bulls' thesis on ACOG. Alpha Cognition Inc. Common Stock (ACOG)'s share was trading at $9.33 as of 30th May. ACOG's forward P/E was 26.88 according to Yahoo Finance. A chemist in a laboratory analyzing data from the various therapeutic tests conducted. Alpha Cognition Inc. (NASDAQ: ACOG) represents a potentially overlooked opportunity in the Alzheimer's treatment space, having recently launched its oral drug, Zunveyl, at the end of March. With a current market cap of $150 million and $45 million in cash, the company is targeting the underserved segment of the Alzheimer's population—specifically, the 50% of patients in long-term care (LTC) not taking any current medications due to severe side effects. Unlike other galantamine-based drugs, Zunveyl significantly slows disease progression and improves short-term memory with a markedly better safety profile—only one serious side-effect case was reported in its Phase 3 trials, versus a 50% rate seen in traditional options. The drug's Medicare coverage further eases affordability, lowering monthly out-of-pocket costs to $30–$190. Initial demand appears promising, with nearly 500 patients starting treatment in the first two weeks of launch. Even a modest 1% market penetration into the LTC segment could yield $135 million in annual revenue, with $67.5 million in net income assuming 50% margins. A 5% penetration would put net income at $675 million, dwarfing the current valuation. Alpha Cognition has also secured a distribution deal with a major Chinese pharmaceutical firm, creating a royalty-based revenue stream in Asia. While the upside is substantial, key risks remain—most notably, the emergence of unforeseen serious side effects post-launch, which could lead to FDA scrutiny or suspension of sales. Still, the market's underreaction and the company's positioning as a safer, effective alternative in a high-need space make ACOG a high-upside, high-conviction bet for risk-tolerant investors. Previously, we have covered ACOG in March 2025 wherein we summarized a by BullishDoctor on Twitter. The user highlighted that Alpha Cognition Inc.'s drug ZUNVEYL addressed the major side effects of existing Alzheimer's treatments, making it highly tolerable and poised for adoption in long-term care facilities, a $2 billion market. The company was pre-revenue but launched in March 2025 with strong physician support, a nearly complete sales force, and promising catalysts like a Phase 4 study and sublingual formulation, projecting breakeven within three years. Since our last coverage, the stock is up 61% as of 30th May. Alpha Cognition Inc. Common Stock (ACOG) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 8 hedge fund portfolios held ACOG at the end of the first quarter which was 10 in the previous quarter. While we acknowledge the potential of ACOG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store